Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ward PS et al. Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. 1991 Br. J. Pharmacol. pmid:1933130
Arimura A et al. Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs. 1994 Br. J. Pharmacol. pmid:7912155
Carmo LG et al. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor. 1985 Br. J. Pharmacol. pmid:2994786
Fitzpatrick TM et al. Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog. 1980 Br. J. Pharmacol. pmid:7000216
Conroy DM et al. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4. 1991 Br. J. Pharmacol. pmid:1725762
Juan H et al. Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis. 1987 Br. J. Pharmacol. pmid:2881590
Bakhle YS et al. Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. 1985 Br. J. Pharmacol. pmid:2996675
Goel RK et al. Effect of ethanol on eicosanoid synthesis by human gastric and colonic mucosal pieces. 1990 Br. J. Pharmacol. pmid:2328396
Bishop-Bailey D et al. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. 1997 Br. J. Pharmacol. pmid:9146896
Provost P et al. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. 1998 Br. J. Pharmacol. pmid:9489613
Hugli TE and Marceau F Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips. 1985 Br. J. Pharmacol. pmid:3921089
Renesto P et al. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine. 1991 Br. J. Pharmacol. pmid:1653073
Coker SJ et al. Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. 1981 Br. J. Pharmacol. pmid:7284679
Zhang BL and Sassard J Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys. 1993 Br. J. Pharmacol. pmid:8220883
Kadiri C et al. Guinea-pig treatment with pertussis toxin suppresses macrophage-dependent bronchoconstriction by fMLP and fails to inhibit the effects of PAF. 1992 Br. J. Pharmacol. pmid:1334747
Desquand S et al. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. 1991 Br. J. Pharmacol. pmid:1285397
Okamura T et al. Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries. 1988 Br. J. Pharmacol. pmid:3359109
Tateson JE et al. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. 1988 Br. J. Pharmacol. pmid:2840160
Tavares-Murta BM et al. Interference of a neutrophil recruitment inhibitory factor upon the accumulation of inflammatory cells and airway hyperreactivity in sensitized guinea-pigs after intranasal antigen challenge. 1993 Br. J. Pharmacol. pmid:7680596
Feuerstein N et al. Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. 1981 Br. J. Pharmacol. pmid:6894882
Bombardieri S et al. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 1981 Br. J. Pharmacol. pmid:6895043
Henrion D et al. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. 1997 Br. J. Pharmacol. pmid:9146891
Milara J et al. Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences. 2010 Br. J. Pharmacol. pmid:20698855
Neupert W et al. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. 1997 Br. J. Pharmacol. pmid:9351505
Aehringhaus U et al. Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis. 1983 Br. J. Pharmacol. pmid:6689134
Köfeler HC et al. Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation. 2000 Br. J. Pharmacol. pmid:10903961
Kuo HL et al. NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry. 2011 Br. J. Pharmacol. pmid:21232029
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Hoult JR and Robinson C Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung. 1983 Br. J. Pharmacol. pmid:6824820
Yin K et al. Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils. 1992 Br. J. Pharmacol. pmid:1393269
Mallarkey G and Smith GM In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs. 1984 Br. J. Pharmacol. pmid:6423018
Boukili MA et al. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. 1986 Br. J. Pharmacol. pmid:3096407
Förster W and Pönicke K Influence of sympathomimetic drugs (1-phenyl-2-amino-ethan-1-ol derivatives) on the biosynthesis of prostaglandins and thromboxane B2. 1983 Br. J. Pharmacol. pmid:6403094
Bennett A et al. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo. 1985 Br. J. Pharmacol. pmid:3840708
Desquand S et al. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086. 1990 Br. J. Pharmacol. pmid:2379029
Riendeau D et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. 1997 Br. J. Pharmacol. pmid:9146894
Lees P et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. 1987 Sep-Oct Br. Vet. J. pmid:3119142
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
McKellar QA et al. Serum thromboxane generation by platelets in several domestic animal species. 1990 Sep-Oct Br. Vet. J. pmid:2224484
Taylor PM et al. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study. 1994 May-Jun Br. Vet. J. pmid:8044665
Lees P and Taylor PM Pharmacodynamics and pharmacokinetics of flunixin in the cat. 1991 Jul-Aug Br. Vet. J. pmid:1913126
Nobutoki T et al. Fluctuating hearing loss, episodic headache, and stroke with platelet hyperaggregability: coexistence of auditory neuropathy and cochlear hearing loss. 2006 Brain Dev. pmid:16168600
Patel PM et al. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. 1994 Brain Res. pmid:7953685
Cach R et al. Microvascular spasm is mediated by vasopressin fibers in the rat hippocampal slice. 1989 Brain Res. pmid:2706515
Busija DW et al. Acetylcholine dramatically increases prostanoid synthesis in piglet parietal cortex. 1988 Brain Res. pmid:3359178
Petroni A et al. Effects of hypoxia and recovery on brain eicosanoids and carbohydrate metabolites in rat brain cortex. 1987 Brain Res. pmid:3607494
Hynes N et al. Leukotrienes in brain: natural occurrence and induced changes. 1991 Brain Res. pmid:1933275
Cach R et al. Blood-borne factors regulating microvascular constriction in the rat hippocampal slice. 1987 Brain Res. pmid:3620912
Hartung HP et al. Recombinant interleukin-1 beta stimulates eicosanoid production in rat primary culture astrocytes. 1989 Brain Res. pmid:2501001
Faden AI et al. Effects of BW755C, a mixed cyclo-oxygenase-lipoxygenase inhibitor, following traumatic spinal cord injury in rats. 1988 Brain Res. pmid:3143469
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Pettigrew LC et al. Delayed elevation of platelet activating factor in ischemic hippocampus. 1995 Brain Res. pmid:8590061
Constable AL et al. Production of prostanoids by Lewis rat Schwann cells in vitro. 1994 Brain Res. pmid:8173981
Andrus PK et al. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion. 1994 Brain Res. pmid:7820653
Ahmad M et al. Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. 2009 Brain Res. pmid:19446533
Aïd S and Bosetti F Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging. 2007 Brain Res. Bull. pmid:17499644
Tuppo EE et al. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. 2001 Brain Res. Bull. pmid:11397549
Akarsu ES et al. Effect of ciliary neurotrophic factor on body temperature and cerebrospinal fluid prostanoids in the cat. 1998 Brain Res. Bull. pmid:9434196
Petroni A et al. Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells. 1994 Brain Res. Dev. Brain Res. pmid:8026072
Petrikova M et al. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets. 2005 Bratisl Lek Listy pmid:15869009
Gajdos M et al. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. 1999 Bratisl Lek Listy pmid:10645034
Kasjanovová D and Baláz V [Functional status of thrombocytes in men of various age groups]. 1990 Bratisl Lek Listy pmid:2224554
Rajec J et al. Biochemical evaluation of the antiplatelet effect of aspirin in patients at different levels of cardiovascular risk. 2008 Bratisl Lek Listy pmid:18814431
Kasjanovová D [Functional status of thrombocytes in men and women in younger age groups]. 1993 Bratisl Lek Listy pmid:8004501
Röth E Effect of Ca-antagonists, beta-blockers and antioxidant during reperfusion period. 1991 Mar-Apr Bratisl Lek Listy pmid:2029661
Lamy M et al. Biochemical pathways of acute lung injury. 1985 May-Jun Bull Eur Physiopathol Respir pmid:3873973
Sakanishi N et al. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock. 1983 Bull. Tokyo Med. Dent. Univ. pmid:6580966
Huang YS et al. Roles of thromboxane and its inhibitor anisodamine in burn shock. 1990 Burns pmid:2257065
Yregård L et al. Influence of local anaesthetics on inflammatory activity postburn. 2003 Burns pmid:12781610
Huang YS et al. Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns. 1998 Burns pmid:9915670
Huang YS et al. Effect of smoke inhalation injury on thromboxane levels and platelet counts. 1988 Burns Incl Therm Inj pmid:3250716
Girotti MJ et al. Comparison of regional pulmonary perfusion in lobar pneumonia during high frequency and conventional mechanical ventilation in sheep. 1987 Can J Anaesth pmid:3581395
Licker M et al. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. 1999 Can J Anaesth pmid:10442956
Byrick RJ et al. Corticosteroids do not inhibit acute pulmonary response to fat embolism. 1990 Can J Anaesth pmid:2193732
Byrick RJ et al. Prostanoid production and pulmonary hypertension after fat embolism are not modified by methylprednisolone. 1991 Can J Anaesth pmid:1934222
Landymore RW et al. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts. 1988 Jan-Feb Can J Cardiol pmid:3359354
Gerrard JM et al. The structured interview elicits a differential prostacyclin response in A and B behaviour types. 1991 Can J Cardiol pmid:2070285
Klein RC et al. Absence of differential inhibition of thromboxane A2 and prostacyclin by low and high dose aspirin in coronary artery disease. 1987 Can J Cardiol pmid:3322532
Shizukuda Y et al. Effect of prednisolone on myocardial infarct healing: characteristics and comparison with indomethacin. 1991 Can J Cardiol pmid:1768984
Chou TZ et al. Effect of felodipine-ER on blood pressure, platelet function, and rheological properties in hypertension. 1993 Can J Cardiol pmid:8394193
Moreno A et al. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. 1995 Can. J. Ophthalmol. pmid:7627895
Tosaki A et al. Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release. 1991 Can. J. Physiol. Pharmacol. pmid:2059911
Datar S et al. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity. 1987 Can. J. Physiol. Pharmacol. pmid:3105853
Rodrigue ME et al. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. 2005 Can. J. Physiol. Pharmacol. pmid:16049546
Gerrard JM Measurements of 6-keto-prostaglandin F1 alpha and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders? 1989 Can. J. Physiol. Pharmacol. pmid:2688855
Kitamura R et al. Thiopental enhances human platelet aggregation by increasing arachidonic acid release. 2001 Can. J. Physiol. Pharmacol. pmid:11697744
Kaushal RD and Wilson TW Effect of furegrelate on renal plasma flow after angiotensin II infusion. 1990 Can. J. Physiol. Pharmacol. pmid:2328452
Liao CH et al. Antiplatelet effect of demethyldiisoeugenol. 1996 Can. J. Physiol. Pharmacol. pmid:9022830
Jancar S et al. Mechanism of action of platelet-activating factor on guinea-pig lung parenchyma strips. 1988 Can. J. Physiol. Pharmacol. pmid:3146431
Smith EF et al. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats. 1980 Can. J. Physiol. Pharmacol. pmid:7378931
Jiang J et al. Endothelin-1 blockade prevents COX2 induction and TXA2 production in the fructose hypertensive rat. 2007 Mar-Apr Can. J. Physiol. Pharmacol. pmid:17612651
Carvalho C et al. Inhibition of airway hyperreactivity, edema, and lung cell infiltration by compound U-83836E in sensitized guinea pigs. 1998 Jul-Aug Can. J. Physiol. Pharmacol. pmid:10030451
Lewis K et al. Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung. 1997 Can. J. Physiol. Pharmacol. pmid:9276148
Jenkins DK et al. Effects of albumin on fatty acid, protein, and eicosanoid levels in rat mesenteric arterial bed perfusions. 1988 Can. J. Physiol. Pharmacol. pmid:3167681
Gibb W et al. Cyclooxygenase products formed by primary cultures of cells from human chorion laeve: influence of steroids. 1988 Can. J. Physiol. Pharmacol. pmid:3167693
Riendeau D et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. 1997 Can. J. Physiol. Pharmacol. pmid:9365818
Jackman BR et al. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin. 1994 Can. J. Vet. Res. pmid:8004539
King JN The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug. 1993 Can. J. Vet. Res. pmid:8269358
Yamamura S et al. Prostaglandin levels of primary bone tumor tissues correlate with peritumoral edema demonstrated by magnetic resonance imaging. 1997 Cancer pmid:9010098
Klausner JM et al. Interleukin-2-induced lung permeability is mediated by leukotriene B4. 1990 Cancer pmid:2173970